Healthcare sector poised for rebound in 2025

The JPMorgan Healthcare Conference is a place where deals happen. As the conference kicked off, deals were announced from Eli Lilly (LLY), Johnson & Johnson (JNJ), and GSK (GSK). Maurits Pot, CEO of Tema ETFs, joins Market Domination to give his predictions for continued M&A growth, specifically within the oncology, neuroscience, and metabolic sectors. Pot reflects on the challenges faced by the healthcare sector in 2024 and the outlook for the coming year. "2024 was, again, a pretty muted year for healthcare M&A, overall, a muted year for the healthcare sector and a number of big companies did not do many big acquisitions," Pot's says. "We think there will be a material pick up this year." Pot also discusses challenges in the GLP-1 market but cites innovation in drug delivery.
#youtube #stocks #news

About Yahoo Finance:

Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life.

- Get the latest news and data at finance.yahoo.com

- Download the Yahoo Finance app on Apple (https://apple.co/3Rten0R) or Android (https://bit.ly/3t8UnXO)

- Follow Yahoo Finance on social:

X: http://twitter.com/YahooFinance
Instagram: https://www.instagram.com/yahoofinance/?hl=en
TikTok: https://www.tiktok.com/@yahoofinance?lang=en
Facebook: https://www.facebook.com/yahoofinance/
LinkedIn: https://www.linkedin.com/company/yahoo-finance